CAD is Associated with Cancer Prognosis and Promotes Enzalutamide Resistance in Prostate Cancer
This study revealed the diagnostic and prognostic potential of CAD. Notably, CAD exhibits essential functions in PCa cell proliferation and enzalutamide resistance.
Authors
- Yu‐Zhong Yu
- Tao Xie (ORCID: https://orcid.org/0000-0002-0580-6877)
- Zefan Zhang (ORCID: https://orcid.org/0000-0001-5627-050X)
- Xianzi Zeng
- Shan‐Chao Zhao (ORCID: https://orcid.org/0000-0002-1162-8077)
- Yongcheng Ren (ORCID: https://orcid.org/0000-0002-8673-4640)
- Maoping Cai
- Qin Li (ORCID: https://orcid.org/0000-0002-9797-2636)
- Xie Xiao
- Ying-Hao Wen (ORCID: https://orcid.org/0000-0002-8515-7757)
- Yi-you Mao
- Baojing Ma
- Hua Zhao
Institutions
- Guangdong University of Education (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Fudan University Shanghai Cancer Center (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Nanfang Hospital (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
- Zhujiang Hospital (CN)
- Jiangxi Pingxiang People's Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Recent Patents on Anti-Cancer Drug Discovery
- Published
- 2025-10-29
- DOI
- https://doi.org/10.2174/0115748928412596251011092220
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00